FIGURE SUMMARY
Title

The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo

Authors
Alburquerque-González, B., Bernabé-García, Á., Bernabé-García, M., Ruiz-Sanz, J., López-Calderón, F.F., Gonnelli, L., Banci, L., Peña-García, J., Luque, I., Nicolás, F.J., Cayuela-Fuentes, M.L., Luchinat, E., Pérez-Sánchez, H., Montoro-García, S., Conesa-Zamora, P.
Source
Full text @ Cancers
Figure 8

Anti-metastatic potential of RAL in zebrafish. (A) At six days post-injection, larvae were examined to evaluate whether micro-metastasis developed by invading native HCT-116 and Fascin1-transfected DLD-1 cells. (B) The evaluation criteria were the presence of human cancer-cell colonies (arrows) outside the yolk sac. Data are shown as mean ± SD; compared with the control condition, ** p = 0.001–0.009. *** p = 0.0001–0.0009.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.